» Articles » PMID: 28242621

A Farnesylated Coxiella Burnetii Effector Forms a Multimeric Complex at the Mitochondrial Outer Membrane During Infection

Overview
Journal Infect Immun
Date 2017 Mar 1
PMID 28242621
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

, the causative agent of Q fever, establishes a unique lysosome-derived intracellular niche termed the -containing vacuole (CCV). The Dot/Icm-type IVB secretion system is essential for the biogenesis of the CCV and the intracellular replication of Effector proteins, translocated into the host cell through this apparatus, act to modulate host trafficking and signaling processes to facilitate CCV development. Here we investigated the role of CBU0077, a conserved effector that had previously been observed to localize to lysosomal membranes. CBU0077 was dispensable for the intracellular replication of in HeLa and THP-1 cells and did not appear to participate in CCV biogenesis. Intriguingly, native and epitope-tagged CBU0077 produced by displayed specific punctate localization at host cell mitochondria. As such, we designated CBU0077 MceA (itochondrial ffector protein ). Analysis of ectopically expressed MceA truncations revealed that the capacity to traffic to mitochondria is encoded within the first 84 amino acids of this protein. MceA is farnesylated by the host cell; however, this does not impact mitochondrial localization. Examination of mitochondria isolated from infected cells revealed that MceA is specifically integrated into the mitochondrial outer membrane and forms a complex of approximately 120 kDa. Engineering to express either MceA tagged with 3×FLAG or MceA tagged with 2×hemagglutinin allowed us to perform immunoprecipitation experiments that showed that MceA forms a homo-oligomeric species at the mitochondrial outer membrane during infection. This research reveals that mitochondria are a bona fide target of effectors and MceA is a complex-forming effector at the mitochondrial outer membrane during infection.

Citing Articles

CRISPR-Cas9-based approaches for genetic analysis and epistatic interaction studies in .

Steiner S, Roy C mSphere. 2024; 9(12):e0052324.

PMID: 39560384 PMC: 11656778. DOI: 10.1128/msphere.00523-24.


Coxiella burnetii protein CBU2016 supports CCV expansion.

Thomas D, Garnish S, Khoo C, Padmanabhan B, Scott N, Newton H Pathog Dis. 2024; 82.

PMID: 39138067 PMC: 11352601. DOI: 10.1093/femspd/ftae018.


co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death.

Loterio R, Thomas D, Andrade W, Lee Y, Santos L, Mascarenhas D Proc Natl Acad Sci U S A. 2023; 120(36):e2308752120.

PMID: 37639588 PMC: 10483631. DOI: 10.1073/pnas.2308752120.


A Novel Marine Mammal -Genome Sequencing Identifies a New Genotype with Potential Virulence.

Gardner B, Bachmann N, Polkinghorne A, Hufschmid J, Tadepalli M, Marenda M Pathogens. 2023; 12(7).

PMID: 37513739 PMC: 10386718. DOI: 10.3390/pathogens12070893.


Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria.

Fisher D, Beare P Front Cell Infect Microbiol. 2023; 13:1202245.

PMID: 37404720 PMC: 10315504. DOI: 10.3389/fcimb.2023.1202245.


References
1.
Omsland A, Cockrell D, Howe D, Fischer E, Virtaneva K, Sturdevant D . Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci U S A. 2009; 106(11):4430-4. PMC: 2657411. DOI: 10.1073/pnas.0812074106. View

2.
Rodriguez-Escudero M, Cid V, Molina M, Schulze-Luehrmann J, Luhrmann A, Rodriguez-Escudero I . Studying Coxiella burnetii Type IV Substrates in the Yeast Saccharomyces cerevisiae: Focus on Subcellular Localization and Protein Aggregation. PLoS One. 2016; 11(1):e0148032. PMC: 4731203. DOI: 10.1371/journal.pone.0148032. View

3.
Franko A, Baris O, Bergschneider E, von Toerne C, Hauck S, Aichler M . Efficient isolation of pure and functional mitochondria from mouse tissues using automated tissue disruption and enrichment with anti-TOM22 magnetic beads. PLoS One. 2013; 8(12):e82392. PMC: 3861405. DOI: 10.1371/journal.pone.0082392. View

4.
Newton P, Latomanski E, Newton H . Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing. J Vis Exp. 2016; (113). PMC: 4993368. DOI: 10.3791/54210. View

5.
Fielden L, Kang Y, Newton H, Stojanovski D . Targeting mitochondria: how intravacuolar bacterial pathogens manipulate mitochondria. Cell Tissue Res. 2016; 367(1):141-154. DOI: 10.1007/s00441-016-2475-x. View